Can a simple ultrasound scan predict who will struggle to swallow during cancer radiotherapy?

NCT ID NCT06387004

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Radiotherapy for head and neck cancer often causes swallowing problems that affect eating, nutrition and quality of life. Current tests for swallowing are invasive, use radiation or are hard to access. This study checks whether ultrasound imaging of the tongue, hyoid bone and throat muscles can predict which patients will develop swallowing problems during radiotherapy. About 112 adults receiving head and neck radiotherapy at one hospital will have ultrasound scans before and during treatment, and researchers will compare those images with swallowing tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound imaging of the tongue, hyoid bone and suprahyoid muscles
What this could lead to
If ultrasound can flag who is likely to develop swallowing problems, doctors could start speech therapy or adjust treatment earlier, when it may help most.
What could go wrong
This is a single-center observational study of about 112 people, so the findings may not hold in other hospitals or patient groups. Ultrasound also depends on the skill of the operator, which can make results inconsistent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

112 people

The number who actually took part.

Started

Jan 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will enroll 124 outpatients initiating head and neck cancer radiotherapy at Forcilles's Hospital over eighteen months. All eligible consecutive patients will undergo screening at admission and provide oral consent.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients admitted to Hôpital Forcilles for head and neck cancer radiotherapy; * Ultrasound operator available ; * Patient at least 18 years old at the time of inclusion; * Membership of a social security scheme or beneficiary of such a scheme ; * Oral, free, informed and express patient consent. Exclusion Criteria: * Patients with neurological disorders; * Patients with DR before the start of radiotherapy; * Patient's refusal to participate in the study ; * Person subject to a safeguard of justice measure ; * Patient under guardianship; * Patient with limited care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Deglutition Disorders head and neck cancer Head and Neck Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Forcilles

    Férolles-Attilly, 77150, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.